Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             32 results found
no title author magazine year volume issue page(s) type
1 Angiosarcoma following MammoSite® partial breast irradiation Andrews, Samuel
2010
124 1 p. 279-282
article
2 Anti-HER2 immunoliposomes for selective delivery of electron paramagnetic resonance imaging probes to HER2-overexpressing breast tumor cells Burks, Scott R.
2010
124 1 p. 121-131
article
3 Approaches and limitations of phosphatidylinositol-3-kinase pathway activation status as a predictive biomarker in the clinical development of targeted therapy Coughlin, Christina M.
2010
124 1 p. 1-11
article
4 Are there racial/ethnic disparities among women younger than 40 undergoing mammography? Kapp, Julie M.
2010
124 1 p. 213-222
article
5 Association of TGFB1 -509 C>T polymorphism with breast cancer: evidence from a meta-analysis involving 23,579 subjects Niu, Wenquan
2010
124 1 p. 243-249
article
6 Beyond bisphosphonates: photodynamic therapy structurally augments metastatically involved vertebrae and destroys tumor tissue Won, Emily
2010
124 1 p. 111-119
article
7 Combined UGT1A1 and UGT1A6 genotypes together with a stressful life event increase breast cancer risk Justenhoven, Christina
2010
124 1 p. 289-292
article
8 Comments on: Sluiter MD and van Rensburg EJ, Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation del Valle, Jesús
2010
124 1 p. 295-296
article
9 Does race modify the association between CYP1B1 Val432Leu polymorphism and breast cancer risk? A critical appraisal of a recent meta-analysis Economopoulos, Konstantinos P.
2010
124 1 p. 293-294
article
10 Effect of neoadjuvant anthracycline–taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study Huober, Jens
2010
124 1 p. 133-140
article
11 17β-Estradiol enhances α5 integrin subunit gene expression through ERα–Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells Sisci, Diego
2010
124 1 p. 63-77
article
12 Fertility drugs and the risk of breast cancer: a meta-analysis and review Zreik, Tony G.
2010
124 1 p. 13-26
article
13 Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics Zuradelli, Monica
2010
124 1 p. 251-258
article
14 Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population Liang, Jie
2010
124 1 p. 237-241
article
15 Identification of a novel BRCA1 nucleotide 4803delCC/c.4684delCC mutation and a nucleotide 249T>A/c.130T>A (p.Cys44Ser) mutation in two Greenlandic Inuit families: implications for genetic screening of Greenlandic Inuit families with high risk for breast and/or ovarian cancer Hansen, Thomas v. O.
2010
124 1 p. 259-264
article
16 Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons Veronesi, Umberto
2010
124 1 p. 141-151
article
17 Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109 Hockla, Alexandra
2009
124 1 p. 27-38
article
18 Multimodal exercise improves quality of life of women being treated for breast cancer, but at what cost? Randomized trial with economic evaluation Haines, Terry P.
2010
124 1 p. 163-175
article
19 Mutation and association analysis of GEN1 in breast cancer susceptibility Turnbull, Clare
2010
124 1 p. 283-288
article
20 New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines Colin, Christelle
2010
124 1 p. 101-110
article
21 Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers Domchek, Susan M.
2010
124 1 p. 195-203
article
22 Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy Clemons, Mark
2010
124 1 p. 177-186
article
23 Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane Study Coleman, Robert E.
2010
124 1 p. 153-161
article
24 Synergistic activity of letrozole and sorafenib on breast cancer cells Bonelli, Mara A.
2010
124 1 p. 79-88
article
25 The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer Gabos, Zsolt
2010
124 1 p. 187-194
article
26 The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis Yao, Lei
2010
124 1 p. 223-227
article
27 The G12 family proteins upregulate matrix metalloproteinase-2 via p53 leading to human breast cell invasion Kim, Eun-Sook
2009
124 1 p. 49-61
article
28 The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells Masri, Selma
2010
124 1 p. 89-99
article
29 TMS, a chemically modified herbal derivative of Resveratrol, induces cell death by targeting Bax Aiyar, Sarah E.
2010
124 1 p. 265-277
article
30 UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs Jin, Wei
2009
124 1 p. 39-48
article
31 Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors Su, H. Irene
2010
124 1 p. 205-211
article
32 XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects Qiu, Li-Xin
2010
124 1 p. 229-235
article
                             32 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands